Detalhe da pesquisa
1.
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model.
Hepatology
; 77(2): 476-488, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921493
2.
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status.
Liver Int
; 42(2): 419-424, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963020
3.
Alcohol use disorder and liver transplant: new perspectives and critical issues.
Korean J Intern Med
; 35(4): 797-810, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241080
4.
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes.
Intern Emerg Med
; 15(1): 37-48, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31919780
5.
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study.
Dig Liver Dis
; 51(6): 870-874, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30824409